These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32461067)

  • 41. SARS-CoV-2: a time for clear and immediate action.
    Poland GA
    Lancet Infect Dis; 2020 May; 20(5):531-532. PubMed ID: 32243818
    [No Abstract]   [Full Text] [Related]  

  • 42. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
    Fox ER; Stolbach AI; Mazer-Amirshahi M
    J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
    [No Abstract]   [Full Text] [Related]  

  • 43. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

  • 44. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

  • 45. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

  • 46. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 47. Chloroquine for COVID-19: rationale, facts, hopes.
    Cortegiani A; Ippolito M; Ingoglia G; Einav S
    Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
    [No Abstract]   [Full Text] [Related]  

  • 48. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 49. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective potential of expectorants against COVID-19.
    Esam Z
    Med Hypotheses; 2020 Sep; 142():109844. PubMed ID: 32930097
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug researchers pursue new lines of attack against COVID-19.
    Harrison C
    Nat Biotechnol; 2020 Jun; 38(6):659-662. PubMed ID: 32417850
    [No Abstract]   [Full Text] [Related]  

  • 52. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
    Magro G
    Travel Med Infect Dis; 2020; 37():101685. PubMed ID: 32334088
    [No Abstract]   [Full Text] [Related]  

  • 53. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
    Patrì A; Fabbrocini G
    J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
    [No Abstract]   [Full Text] [Related]  

  • 54. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
    Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
    Poulas K; Farsalinos K; Zanidis C
    Front Immunol; 2020; 11():1373. PubMed ID: 32612613
    [No Abstract]   [Full Text] [Related]  

  • 57. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
    Bollyky TJ; Gostin LO; Hamburg MA
    JAMA; 2020 Jun; 323(24):2462-2463. PubMed ID: 32379268
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical consideration and management of coronavirus disease 2019].
    Ma K; Chen T; Han MF; Guo W; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):222-228. PubMed ID: 32306656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.